Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-08-10 5:26 pm Purchase | 13G | Impel Pharmaceuticals Inc. IMPL | Norwest Venture Partners XIV LP | 3,077,198 13.81% | 3,077,198 (New Position) | View |
| 2021-05-07 4:30 pm Purchase | 13D | Impel Pharmaceuticals Inc. IMPL | KKR Iris Investors LLC | 3,802,638 19.6% | 3,802,638 (New Position) | View |
| 2021-05-07 4:18 pm Purchase | 13G | Impel Pharmaceuticals Inc. IMPL | 5AM Ventures V L.P. | 2,884,791 14.9% | 2,884,791 (New Position) | View |
| 2021-05-07 1:01 pm Purchase | 13G | Impel Pharmaceuticals Inc. IMPL | venBio Global Strategic Fund II L.P. | 2,759,791 14.2% | 2,759,791 (New Position) | View |
| 2021-05-06 4:30 pm Purchase | 13G | Impel Pharmaceuticals Inc. IMPL | Vivo Capital VIII LLC | 2,884,789 14.9% | 2,884,789 (New Position) | View |